Evidence map›Paper›PMID 24956278›Full record

ArticlePloS one2014

Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK.

Jordan J Toutounchian, Jena J Steinle, Patrudu S Makena, Christopher M Waters, Matthew W Wilson, Barrett G Haik, Duane D Miller, Charles R Yates

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Role of p53 in Regulating Radiation Responses.Life (Basel, Switzerland) · 2022
    Review
  6. The individual and combined effects of spaceflight radiation and microgravity on biologic systems and functional outcomes.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2021
    Article
  7. Article
  8. Paxillin: a crossroad in pathological cell migration.Journal of hematology & oncology · 2017
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jordan J ToutounchianDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Jena J SteinleDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Patrudu S MakenaDepartment of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Christopher M WatersDepartment of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Matthew W WilsonDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Barrett G HaikDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Duane D MillerDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Charles R YatesDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
University of Tennessee Health Science Center · US

Funding

CORE--MOLECULAR BIOLOGYP30EY013080 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JOHNSON, DIANNA AMMONS · 2000 to 2010
$3.7M
Vision Research CoreP30EY021721 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2011 to 2015
$2.8M
Mechanotransduction in Acute Lung InjuryR01HL094366 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WATERS, CHRISTOPHER M · 2009 to 2012
$2.1M
Treatment with KZ-41 and OTP promotes wound healing in a radiation combined injurR33AI080534 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI MILLER, DUANE D · 2010 to 2012
$1.1M
NEI NIH HHS 3P30 EY013080NEI NIH HHS P30 EY013080NEI NIH HHS P30 EY021721NHLBI NIH HHS HL094366NHLBI NIH HHS R01 HL094366NIAID NIH HHS R33 AI080534NIAID NIH HHS R33 AI080534-01
6 · The paper itself

Abstract

Radiation-induced damage to the retina triggers leukostasis, retinal endothelial cell (REC) death, and subsequent hypoxia. Resultant ischemia leads to visual loss and compensatory retinal neovascularization (RNV). Using human RECs, we demonstrated that radiation induced leukocyte adhesion through mechanisms involving p38MAPK, p53, and ICAM-1 activation. Additional phenotypic changes included p38MAPK-dependent tyrosine phosphorylation of the focal adhesion scaffolding protein, paxillin (Tyr118). The quinic acid derivative KZ-41 lessened leukocyte adhesion and paxillin-dependent proliferation via inhibition of p38MAPK-p53-ICAM-1 signaling. Using the murine oxygen-induced retinopathy (OIR) model, we examined the effect of KZ-41 on pathologic RNV. Daily ocular application of a KZ-41-loaded nanoemulsion significantly reduced both the avascular and neovascular areas in harvested retinal flat mounts when compared to the contralateral eye receiving vehicle alone. Our data highlight the potential benefit of KZ-41 in reducing both the retinal ischemia and neovascularization provoked by genotoxic insults. Further research into how quinic acid derivatives target and mitigate inflammation is needed to fully appreciate their therapeutic potential for the treatment of inflammatory retinal vasculopathies.

Indexed as

MAP Kinase Signaling SystemRadiation Injuries, ExperimentalRetinaRetinal DiseasesRetinal VesselsAnimalsEndothelial CellsGamma RaysHumansIntercellular Adhesion Molecule-1Micep38 Mitogen-Activated Protein KinasesQuinic AcidTumor Suppressor Protein p53U937 CellsICAM1 protein, humanIntercellular Adhesion Molecule-1KZ 41 compoundp38 Mitogen-Activated Protein KinasesQuinic AcidTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID24956278
PMCPMC4067294
OpenAlexW2022636024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.